AIM ImmunoTech (HXB) Revenue

1 Followers

AIM ImmunoTech Revenue

AIM ImmunoTech had a revenue of 26.00K in the quarter ending Jun 30, 2026, with 23.81%. This bring the company's revenue in the last twelve months to 95.00K, Decreased 7.95%. In the fiscal year ending Mar 31, 2026, AIM ImmunoTech had annual revenue of 88.00K with -48.24% growth.

Revenue (ttm)

95.00K

Revenue Growth

―

P/S Ratio

74.31

Revenue/Employee

€4,632

Employees

Market Cap

€6.54M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Mar 31, 2026	88.00K	-82.00K	-48.24%
Dec 31, 2024	170.00K	-32.00K	-15.84%
Mar 31, 2024	202.00K	61.00K	+43.26%
Mar 31, 2023	141.00K	6.00K	+4.44%
Mar 31, 2022	135.00K	-28.00K	-17.18%
Mar 31, 2021	163.00K	23.00K	+16.43%
Mar 31, 2020	140.00K	-227.00K	-61.85%
Mar 31, 2019	367.00K	-70.00K	-16.02%
Dec 31, 2017	437.00K	―	―